System offers new option to treat mitral regurgitation

In a novel procedure, the Vanderbilt Heart & Vascular Institute (VHVI) successfully performed the first large-flange Innovalve transcatheter mitral valve replacement.

Novel device helps extend window of time to preserve hearts donated after cardiac death

In the first such procedure, Vanderbilt University Medical Center has transplanted a DCD (donation after cardiac death) heart using XVIVO Heart Assist Transport (XHAT), a novel cold organ perfusion device.

Bird flu vaccine more effective with potent adjuvant

The avian (bird) influenza vaccine creates a more robust immune response when paired with a potent ingredient known as an adjuvant, according to Vanderbilt research published in The Journal of Infectious Diseases.

VUMC receives $13 million grant to coordinate multisite clinical trial for Rett syndrome treatment

Vanderbilt University Medical Center received a $13 million Department of Defense grant to lead a multisite clinical trial that will evaluate repurposed FDA-approved drugs as treatment options for patients with Rett syndrome.

Study shows liraglutide results in increased insulin sensitivity independent of weight loss

Clinical trial shows efficacy for atezolizumab combined with carboplatin